Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Meet the Company That’s Creating Cannabis Through Art & Science

(Click to watch video) Adastra Labs Holdings Ltd. ( CSE.XTRX , OTC: XTXXF , Forum ) is a leading manufacturer and supplier of innovative ethno-botanical and cannabis science products designed for the adult-use and medical markets and forward-looking therapeu...
Dave Jackson | October 26, 2021 |

Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug

Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...
Streetwise Reports | December 27, 2019 |

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...
Streetwise Reports | August 28, 2019 |

The Dales Report panelists agree on this vote: Way to go, Ohio

Welcome to the Trade To Black podcast on Stockhouse.com . In the episode in the above video, Shadd Dales, Anthony Varrell and Benjamin Smith talk in-depth about the following stories and more: Ohio voters approve the legalization of adult use cannabis ...
The Dales Report | November 9, 2023 |

'This is Amazing': Technical Analyst Rates Oil & Gas Small Cap Strong Speculative Buy

Technical analyst Clive Maund details the fundamentals for this oil & gas firm and explains why he sees it as a strong speculative buy. After a prolonged period of adversity and depression it looks like Amazing Energy Oil & Gas Co. (AMAZ:OTCQX) has at last "cleaned ...
Streetwise Reports | November 26, 2019 |

ICAN Leverages Leading California Brand with Expansion into Nevada, ...

ICAN Leverages Leading California Brand with Expansion into Nevada, Introduces State-of-the-Art Pre-Roll Machine, for Aggressive Near-Term Growth A recent acquisition is helping this company to expand its brand. If a customer at any of the popular recreational ...
Streetwise Reports | November 21, 2019 |

Buzz on the Bullboards: 2021’s Highlights

2021 was another year of ups, downs, and everything in between, but it was also a year marked by continued global economic uncertainty and a shakeup of some of the hottest investment sectors. I took notice when I realized how often I had been updating my template...
Stockhouse Editorial | December 15, 2021 |

Best-in-class Cannabis = Best-in-class Investment Opportunity

(CLICK IMAGE TO PLAY VIDEO) Today, in the publicly-traded retail cannabis sector, you need to deliver not only a quality, brand-name product but consistent shareholder value. Enter the new name in the game – Chalice Brands Ltd. ( CSE.CHAL , OTCMKTS: CHALF...
Dave Jackson | July 8, 2021 |

Growing Rapidly and Efficiently in California's Cannabis Market

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Omri Wallach was recently joined live by Arni ...
Omri Wallach | September 30, 2019 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |
1 2 3 4 5 6 7 8 9 10 ...